Pulmonary Langerhans cell histiocytosis presenting as a solitary nodule

A Khoor1, J L Myers, H D Tazelaar

  • 1Department of Pathology, Mayo Clinic, Jacksonville, Fla., USA.

Mayo Clinic Proceedings
|February 24, 2001
PubMed

Insights

Pulmonary Langerhans cell histiocytosis (PLCH) can present as a solitary pulmonary nodule. This rare manifestation does not necessarily indicate interstitial lung disease, even with new nodule formation.

Area of Science:

  • Pulmonology
  • Oncology
  • Pathology

Background:

  • Pulmonary Langerhans cell histiocytosis (PLCH) is a rare lung disease.
  • PLCH commonly presents with diffuse lung involvement, often interstitial disease.
  • Solitary pulmonary nodules are an uncommon presentation of PLCH.

Observation:

  • A case of a 45-year-old male smoker with an asymptomatic solitary pulmonary nodule is presented.
  • The nodule exhibited histologic and immunophenotypic features of PLCH.
  • The patient remained asymptomatic with no interstitial disease 21 years post-excision.

Findings:

  • A new contralateral lung nodule developed 21 years after initial diagnosis.
  • The new nodule remained stable over 36 months of observation.
  • This case highlights PLCH as a cause of isolated pulmonary nodules.

Implications:

  • Solitary pulmonary nodules in PLCH may not predict interstitial lung disease.
  • PLCH should be considered in the differential diagnosis of solitary pulmonary nodules.
  • This case expands the understanding of PLCH clinical presentations.